XML 48 R26.htm IDEA: XBRL DOCUMENT v3.24.4
BASIS OF PRESENTATION (Tables)
 12 Months Ended
Sep. 30, 2024
BASIS OF PRESENTATION  
Schedule of Functional Currency of Company and its Subsidiaries

​

​

​

​

​

​

​

​

​

    

Country of

    

Effective

    

Functional

​

​

Incorporation

​

Interest

​

Currency

​

​

​

​

​

​

​

ESSA Pharma Inc.

 

Canada

 

—

 

US Dollar

ESSA Pharmaceuticals Corp.

 

USA

 

100

%  

US Dollar